Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 253

1.

Prevalence of migraine in Han Chinese of Fujian province: An epidemiological study.

Lin QF, Xia QQ, Zeng YL, Wu XY, Ye LF, Yao LT, Xin YT, Huang GB.

Medicine (Baltimore). 2018 Dec;97(52):e13500. doi: 10.1097/MD.0000000000013500.

2.

Pacemaker implantation for treating migraine-like headache secondary to cardiac arrhythmia: A case report.

Man YH, Meng XL, Yu TM, Yao G.

Medicine (Baltimore). 2018 Dec;97(50):e13629. doi: 10.1097/MD.0000000000013629.

3.

My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed.

Martelletti P, Schwedt TJ, Lanteri-Minet M, Quintana R, Carboni V, Diener HC, Ruiz de la Torre E, Craven A, Rasmussen AV, Evans S, Laflamme AK, Fink R, Walsh D, Dumas P, Vo P.

J Headache Pain. 2018 Nov 27;19(1):115. doi: 10.1186/s10194-018-0946-z.

4.

Cognitive dysfunction and migraine.

Vuralli D, Ayata C, Bolay H.

J Headache Pain. 2018 Nov 15;19(1):109. doi: 10.1186/s10194-018-0933-4. Review.

5.

Monitoring Migraine Cycle Dynamics with an Easy-to-Use Electrophysiological Marker-A Pilot Study.

Shahaf G, Kuperman P, Bloch Y, Yariv S, Granovsky Y.

Sensors (Basel). 2018 Nov 14;18(11). pii: E3918. doi: 10.3390/s18113918.

6.

Low-dose Ketamine Does Not Improve Migraine in the Emergency Department: A Randomized Placebo-controlled Trial.

Etchison AR, Bos L, Ray M, McAllister KB, Mohammed M, Park B, Phan AV, Heitz C.

West J Emerg Med. 2018 Nov;19(6):952-960. doi: 10.5811/westjem.2018.8.37875. Epub 2018 Sep 10.

7.

The validation of the Hungarian version of the ID-migraine questionnaire.

Csépány É, Tóth M, Gyüre T, Magyar M, Bozsik G, Bereczki D, Juhász G, Ertsey C.

J Headache Pain. 2018 Nov 12;19(1):106. doi: 10.1186/s10194-018-0938-z.

8.

A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine.

Camporeale A, Kudrow D, Sides R, Wang S, Van Dycke A, Selzler KJ, Stauffer VL.

BMC Neurol. 2018 Nov 9;18(1):188. doi: 10.1186/s12883-018-1193-2.

9.

Migraine induction with calcitonin gene-related peptide in patients from erenumab trials.

Christensen CE, Younis S, Deen M, Khan S, Ghanizada H, Ashina M.

J Headache Pain. 2018 Nov 8;19(1):105. doi: 10.1186/s10194-018-0927-2.

10.

Effects of topical vs injection treatment of cervical myofascial trigger points on headache symptoms in migraine patients: a retrospective analysis.

Affaitati G, Costantini R, Tana C, Lapenna D, Schiavone C, Cipollone F, Giamberardino MA.

J Headache Pain. 2018 Nov 8;19(1):104. doi: 10.1186/s10194-018-0934-3.

11.

Management of refractory chronic migraine using ultrasound-guided pulsed radiofrequency of greater occipital nerve: Two case reports.

Kwak S, Chang MC.

Medicine (Baltimore). 2018 Nov;97(45):e13127. doi: 10.1097/MD.0000000000013127.

12.

Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial.

Martelletti P, Barbanti P, Grazzi L, Pierangeli G, Rainero I, Geppetti P, Ambrosini A, Sarchielli P, Tassorelli C, Liebler E, de Tommaso M; PRESTO Study Group.

J Headache Pain. 2018 Nov 1;19(1):101. doi: 10.1186/s10194-018-0929-0. Erratum in: J Headache Pain. 2018 Dec 18;19(1):120.

13.

The role of state and trait positive affect and mindfulness in affective reactivity to pain in chronic migraine.

Ciere Y, Snippe E, Padberg M, Jacobs B, Visser A, Sanderman R, Fleer J.

Health Psychol. 2019 Jan;38(1):94-102. doi: 10.1037/hea0000692. Epub 2018 Oct 29.

PMID:
30372104
14.

Pharmacogenetic considerations for migraine therapies.

Capi M, Gentile G, Lionetto L, Salerno G, Cipolla F, Curto M, Borro M, Martelletti P.

Expert Opin Drug Metab Toxicol. 2018 Nov;14(11):1161-1167. doi: 10.1080/17425255.2018.1541452. Epub 2018 Nov 1. Review.

PMID:
30362834
15.

Anatomical Look Into OnabotulinumtoxinA Injection for Chronic Migraine Headache.

Wu-Fienberg Y, Ansari H, Zardouz S, Narouze S, Blaha T, Swanson M, Totonchi A.

Reg Anesth Pain Med. 2018 Nov;43(8):869-874. doi: 10.1097/AAP.0000000000000818.

PMID:
30346346
16.

Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial.

Grazzi L, Tassorelli C, de Tommaso M, Pierangeli G, Martelletti P, Rainero I, Geppetti P, Ambrosini A, Sarchielli P, Liebler E, Barbanti P; PRESTO Study Group.

J Headache Pain. 2018 Oct 19;19(1):98. doi: 10.1186/s10194-018-0928-1. Erratum in: J Headache Pain. 2019 Jan 7;20(1):1.

17.

Symptoms of premenstrual syndrome in female migraineurs with and without menstrual migraine.

Vetvik KG, MacGregor EA, Lundqvist C, Russell MB.

J Headache Pain. 2018 Oct 17;19(1):97. doi: 10.1186/s10194-018-0931-6.

18.

Comorbidity of migraine with ADHD in adults.

Hansen TF, Hoeffding LK, Kogelman L, Haspang TM, Ullum H, Sørensen E, Erikstrup C, Pedersen OB, Nielsen KR, Hjalgrim H, Paarup HM, Werge T, Burgdorf K.

BMC Neurol. 2018 Oct 16;18(1):147. doi: 10.1186/s12883-018-1149-6.

19.

Topically applied linoleic/linolenic acid for chronic migraine.

Santos C, Weaver DF.

J Clin Neurosci. 2018 Dec;58:200-201. doi: 10.1016/j.jocn.2018.10.013. Epub 2018 Oct 11.

PMID:
30316628
20.

Multimodal MRI-based classification of migraine: using deep learning convolutional neural network.

Yang H, Zhang J, Liu Q, Wang Y.

Biomed Eng Online. 2018 Oct 11;17(1):138. doi: 10.1186/s12938-018-0587-0.

Supplemental Content

Loading ...
Support Center